| Post-line Treatment with Teniposide for C-Myc-driven Extensive-stage Small Cell Lung Cancer | Phase II Clinical Study to Evaluate the Efficacy and Safety of Teniposide As a Post-Line Therapy for C-Myc-Driven Extensive-Stage Small Cell Lung Cancer | NCT06758700 |
| Teniposide Incorporating Bu/Cy Conditioning Regimen for HLH With Central Nervous System Involvemen | Teniposide Incorporating Bu/Cy Conditioning Regimen Followed by HSCT for HLH With Central Nervous System Involvement: a Prospective Single-arm Clinical Study | NCT06048107 |
| Phase II Clinical Study to Evaluate the Efficacy and Safety of Teniposide as a Post-Line Therapy for c-Myc-Driven Extensive-Stage Small Cell Lung Cancer | Phase II Clinical Study to Evaluate the Efficacy and Safety of Teniposide as a Post-Line Therapy for c-Myc-Driven Extensive-Stage Small Cell Lung Cancer | ChiCTR2400094090 |
| Ifosfamide, Teniposide, and Paclitaxel in Treating Patients With Relapsed Non-Hodgkin's Lymphoma | Phase I/II Study of Mesna, Ifosfamide, Teniposide and Weekly Taxol (MITTen) in Relapsed Lymphoma | NCT00004916 |
